Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (5) , 195-197
- https://doi.org/10.1016/s1471-4914(02)02332-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Repeat expansion and neurological diseasePublished by Cambridge University Press (CUP) ,2002
- Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular ToxicityScience, 2001
- Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalizationNature Neuroscience, 2000
- Huntington's disease: the challenge for cell biologistsTrends in Cell Biology, 2000
- CREB-binding protein sequestration by expanded polyglutamineHuman Molecular Genetics, 2000
- Transcriptional dysregulation in Huntington’s diseaseTrends in Neurosciences, 2000
- The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcriptionProceedings of the National Academy of Sciences, 2000
- Decreased expression of striatal signaling genes in a mouse model of Huntington's diseaseHuman Molecular Genetics, 2000
- Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear InclusionsCell, 1998
- Ataxin-1 Nuclear Localization and AggregationCell, 1998